Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
about
Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent modelsA lectin isolated from bananas is a potent inhibitor of HIV replicationThe hepatitis C virus glycan shield and evasion of the humoral immune responseHIV-1 gp120 as a therapeutic target: navigating a moving labyrinthGlycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodiesMicrobicides and other topical agents in the prevention of HIV and sexually transmitted infections.The Patterns of Coevolution in Clade B HIV Envelope's N-Glycosylation SitesMicrovirin, a novel alpha(1,2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile.Algal lectins as potential HIV microbicide candidatesRole of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions.Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopesInhibition of hepatitis C virus 3a genotype entry through Glanthus Nivalis Agglutinin.The highly conserved glycan at asparagine 260 of HIV-1 gp120 is indispensable for viral entryPradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus.What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin.High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization.Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?Rhizosecretion improves the production of Cyanovirin-N in Nicotiana tabacum through simplified downstream processingConservation, Compensation, and Evolution of N-Linked Glycans in the HIV-1 Group M Subtypes and Circulating Recombinant Forms.Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA.Potential of carbohydrate-binding agents as therapeutics against enveloped viruses.Bitter-sweet symphony: glycan-lectin interactions in virus biology.High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120.Strict specificity for high-mannose type N-glycans and primary structure of a red alga Eucheuma serra lectin.Lectins with anti-HIV activity: a review.Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.Antiviral lectins: Selective inhibitors of viral entry.Transformation of Althaea officinalis L. by Agrobacterium rhizogenes for the production of transgenic roots expressing the anti-HIV microbicide cyanovirin-N.Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120.NICTABA and UDA, two GlcNAc-binding lectins with unique antiviral activity profiles.Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans.High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120.Cloning and functional characterization of a GNA-like lectin from Chinese Narcissus (Narcissus tazetta var. Chinensis Roem).Secretory Expression and Characterization of Chinese Narcissus GNA-Like Lectin in Pichia pastoris.Alterations of high-mannose type N-glycosylation in human and mouse osteoarthritis cartilage.An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development.Protein glycosylation in infectious disease pathobiology and treatmentPathobiology of virus glycosylation: implications to disease and prospects for treatment
P2860
Q24610025-3CD3561F-B4C4-4D6F-9D3F-C61437C5C25AQ24629155-119ECFEA-FAD9-496A-BA8C-40DC1CCF703EQ27023390-D0DF1749-2D2C-43BC-A22B-21FB1159CD3AQ28086826-AD73CE3A-0940-48C1-ACD7-CFC8E8E6D76FQ28263932-C3758683-A5EC-4794-A638-6723518E1B4CQ30359545-5195EE52-3EA4-4BD7-AB9C-47B6D7364212Q30376065-1822EB8A-74FA-40BC-A7BA-DC8BEFF54F01Q34042738-6B93E258-B986-46BD-A21E-994D657C9251Q34291727-42E88E24-CEB5-43CA-A4B8-58CD0538997EQ34295953-72D6D9B2-C1B2-43E0-9C81-FDAFB2ABECF3Q35024164-80C050C6-6236-4E48-83B3-F109DD20B2C9Q35053124-8FDC3614-6F10-4F19-B4CC-101A01265CFEQ35604541-F734F018-7377-48E7-BB80-B0E34DC7A2E6Q35634404-C29BD52C-20F1-40B2-9326-37EF32EBD3E4Q35641144-562E984D-357E-4372-85D0-12133AF13560Q36107520-D206D7CC-60C3-4DD3-BB60-1D2E3EBA3BF8Q36237904-8C953DA1-2C73-4F95-8510-5C8155DA401AQ36758492-E26D3E43-A20C-4A60-979F-CDB2327EDC91Q37056391-1B7A848A-D422-496F-885F-75C476CE0E77Q37153097-BC19BAFF-8FFA-4BEB-B978-FA9D121D37A2Q37208595-4C0D819B-BD13-47A0-8906-9CB320AEEB22Q37533386-981B04D0-913E-4D00-AF56-710B0A22E0EEQ37767654-5B2934DE-EDFF-4159-AB5D-DE14C71E46EBQ38159719-EF3736D9-DA65-4140-ADA5-2F3A36CBE56BQ38294806-455F1CC5-83FC-4DD4-982B-E1876E85B21AQ38305332-7B7BDAE7-2297-497B-A433-D7CC951FA6FCQ38311332-35CB8600-1A42-42B3-9515-18A4AE674693Q38343814-A8878581-9D5D-4C83-A928-34C37B026519Q38891044-9F99FE5F-2409-469E-A9E1-9DF70C357575Q39385021-BE1EF403-0DCC-4666-B84E-F4D296B6917EQ40128614-0BEBEE76-1E2D-436D-8595-8919928C83BBQ40168596-39BD1F44-4B94-43D8-9819-29C7020A585DQ40261250-5AC1C9A0-E417-4764-94D5-5A60C68B4AFEQ41107113-94606394-63E6-4DB5-9A9C-5FBD2B89CAA8Q42687316-7BCCBB0B-DEB1-4EE6-96D0-5FF60D47262AQ51026317-00543B08-4DD1-4DD9-A244-F0A6AA045185Q54354529-7B5967C9-123D-45D2-ADA2-C3302A99CE2DQ55516259-AF0F53DE-8D2E-4A42-91AD-00218888A243Q57202107-567F4335-8819-4E19-8C92-4B4BC6A2A74FQ57202110-B522E1E4-F14E-48D7-945F-8B406AE446EE
P2860
Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Resistance of human immunodefi ...... anovirin N and concanavalin A.
@en
type
label
Resistance of human immunodefi ...... anovirin N and concanavalin A.
@en
prefLabel
Resistance of human immunodefi ...... anovirin N and concanavalin A.
@en
P2093
P2860
P1433
P1476
Resistance of human immunodefi ...... anovirin N and concanavalin A.
@en
P2093
Anders Bolmstedt
Anke Hantson
Barry R O'keefe
James McMahon
Leonidas Stamatatos
Myriam Witvrouw
Valery Fikkert
P2860
P304
P356
10.1128/JVI.79.12.7777-7784.2005
P577
2005-06-01T00:00:00Z